Cheryl Ho

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Solange Peters, Scott Gettinger, Melissa L. Johnson et al. · Journal of Clinical Oncology · 2017 · 419 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 244 citations

Medicine, Oncology, Pharmacology +16

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Valsamo Anagnostou, Cheryl Ho, Garth Nicholas et al. · Nature Medicine · 2023 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

EGFR mutation status on brain metastases from non-small cell lung cancer

Fred Hsu, Alex De Caluwé, David W. Anderson et al. · Lung Cancer · 2016 · 134 citations

Medicine, Molecular Genetics, Oncology +14

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

Janessa Laskin, Steven J.M. Jones, Samuel Aparício et al. · Molecular Case Studies · 2015 · 113 citations · Full text

Medicine, Molecular Medicine, Oncology +17